Literature DB >> 19936790

Transformation potential of bone marrow stromal cells into undifferentiated high-grade pleomorphic sarcoma.

Qing Li1, Hiroko Hisha, Takashi Takaki, Yasushi Adachi, Ming Li, Changye Song, Wei Feng, Satoshi Okazaki, Tomomi Mizokami, Junko Kato, Muneo Inaba, Naoki Hosaka, Masahiko Maki, Susumu Ikehara.   

Abstract

PURPOSE: Bone marrow adherent cells contain conventional bone marrow stromal cells and mesenchymal stem cells and these cells constitute the hematopoietic microenvironment. Mesenchymal stem cells have the capacity to give rise to multiple mesenchymal lineage cells and even ectodermal lineage cells. In the present study, we investigated what types of tumor cells are inducible from BM adherent cells by chemical carcinogens.
METHODS: Bone marrow cells from neonatal C3H/HeN mice were collected within 24 h after birth and then cultured. Four days later, bone marrow adherent cells were obtained and the cells were treated with 3-methylcholanthrene.
RESULTS: By this treatment, some transformed clones consisting of large spindle cells were obtained. The transformed cells were highly positive for CD44 and were positive for Sca-1, CD49d and CD106, whereas the cells were negative for hematolymphoid markers. The cell clones had the ability to support hematopoiesis in vitro. These results indicate that the transformed cell lines have the characteristics of BM stromal cells/mesenchymal stem cells. Moreover, during culture of the transformed cells, spontaneous bone nodule formation was observed. When the transformed cells were inoculated into immunodeficient mice subcutaneously, the neoplasms grew in the subcutaneous tissue of the mice. Microscopically and ultrastructurally, the neoplasms showed the typical morphology of undifferentiated high-grade pleomorphic sarcoma (UHGPS). Bone-related genes have been found to be expressed in both transformed cells and UHGPSs.
CONCLUSION: The present study suggests that UHGPSs are derived from BM stromal cells, probably mesenchymal stem cells.

Entities:  

Mesh:

Year:  2009        PMID: 19936790     DOI: 10.1007/s00432-009-0723-0

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  30 in total

1.  Adult rat and human bone marrow stromal cells differentiate into neurons.

Authors:  D Woodbury; E J Schwarz; D J Prockop; I B Black
Journal:  J Neurosci Res       Date:  2000-08-15       Impact factor: 4.164

Review 2.  Malignant fibrous histiocytoma: past, present, and future.

Authors:  A E Rosenberg
Journal:  Skeletal Radiol       Date:  2003-09-27       Impact factor: 2.199

3.  Adipogenic, osteogenic and myofibrogenic differentiations of a rat malignant fibrous histiocytoma (MFH)-derived cell line, and a relationship of MFH cells with embryonal mesenchymal, perivascular and bone marrow stem cells.

Authors:  Jyoji Yamate; Keiko Ogata; Takahiro Yuasa; Mitsuru Kuwamura; Shigeo Takenaka; Daijirou Kumagai; Kazuyuki Itoh; Jonathan LaMarre
Journal:  Eur J Cancer       Date:  2007-12       Impact factor: 9.162

4.  Malignant fibrous histiocytoma. Evidence of perivascular mesenchymal cell origin immunocytochemical studies with monoclonal anti-MFH antibodies.

Authors:  H Iwasaki; T Isayama; H Johzaki; M Kikuchi
Journal:  Am J Pathol       Date:  1987-09       Impact factor: 4.307

5.  Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division.

Authors:  C A Reznikoff; J S Bertram; D W Brankow; C Heidelberger
Journal:  Cancer Res       Date:  1973-12       Impact factor: 12.701

6.  In vitro transformation of normal cells to tumor cells by carcinogenic hydrocarbons.

Authors:  Y Berwald; L Sachs
Journal:  J Natl Cancer Inst       Date:  1965-10       Impact factor: 13.506

7.  Malignant fibrous histiocytoma tumor cells resemble fibroblasts.

Authors:  G S Wood; J H Beckstead; R R Turner; M R Hendrickson; R L Kempson; R A Warnke
Journal:  Am J Surg Pathol       Date:  1986-05       Impact factor: 6.394

8.  Myofibroblastic differentiation in malignant fibrous histiocytoma (pleomorphic myofibrosarcoma): a clinicopathological study.

Authors:  E Montgomery; C Fisher
Journal:  Histopathology       Date:  2001-06       Impact factor: 5.087

9.  Muscle regeneration by bone marrow-derived myogenic progenitors.

Authors:  G Ferrari; G Cusella-De Angelis; M Coletta; E Paolucci; A Stornaiuolo; G Cossu; F Mavilio
Journal:  Science       Date:  1998-03-06       Impact factor: 47.728

10.  Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization.

Authors:  Lindolfo da Silva Meirelles; Nance Beyer Nardi
Journal:  Br J Haematol       Date:  2003-11       Impact factor: 6.998

View more
  10 in total

Review 1.  The role of mesenchymal stem/progenitor cells in sarcoma: update and dispute.

Authors:  Jilong Yang; Zhiwu Ren; Xiaoling Du; Mengze Hao; Wenya Zhou
Journal:  Stem Cell Investig       Date:  2014-10-27

Review 2.  Do mesenchymal stem cells function across species barriers? Relevance for xenotransplantation.

Authors:  Jiang Li; Mohamed B Ezzelarab; David K C Cooper
Journal:  Xenotransplantation       Date:  2012 Sep-Oct       Impact factor: 3.907

3.  Local mesenchymal stem/progenitor cells are a preferential target for initiation of adult soft tissue sarcomas associated with p53 and Rb deficiency.

Authors:  Jinhyang Choi; Stephen J Curtis; David M Roy; Andrea Flesken-Nikitin; Alexander Yu Nikitin
Journal:  Am J Pathol       Date:  2010-09-23       Impact factor: 4.307

4.  Intervention effect of pinelliae decoction for purging stomach-fire on malignant transformation of bone marrow mesenchymal stem cells in the gastric cancer microenvironment.

Authors:  Xi-Ping Liu; Hai-Xia Ming; Pei-Qing Li
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

5.  Complement activation promoted by the lectin pathway mediates C3aR-dependent sarcoma progression and immunosuppression.

Authors:  Elena Magrini; Sabrina Di Marco; Sarah N Mapelli; Chiara Perucchini; Fabio Pasqualini; Alessia Donato; Maria de la Luz Guevara Lopez; Roberta Carriero; Andrea Ponzetta; Piergiuseppe Colombo; Ferdinando Cananzi; Domenico Supino; Edimara S Reis; Clelia Peano; Antonio Inforzato; Sebastien Jaillon; Andrea Doni; John D Lambris; Alberto Mantovani; Cecilia Garlanda
Journal:  Nat Cancer       Date:  2021-02-18

6.  Mesenchymal stem cell transformation and sarcoma genesis.

Authors:  Wei Xiao; Alexander B Mohseny; Pancras C W Hogendoorn; Anne-Marie Cleton-Jansen
Journal:  Clin Sarcoma Res       Date:  2013-07-23

Review 7.  Soft Tissue Sarcoma Cancer Stem Cells: An Overview.

Authors:  Katia C Genadry; Silvia Pietrobono; Rossella Rota; Corinne M Linardic
Journal:  Front Oncol       Date:  2018-10-26       Impact factor: 6.244

8.  Neutrophils Driving Unconventional T Cells Mediate Resistance against Murine Sarcomas and Selected Human Tumors.

Authors:  Andrea Ponzetta; Roberta Carriero; Silvia Carnevale; Marialuisa Barbagallo; Martina Molgora; Chiara Perucchini; Elena Magrini; Francesca Gianni; Paolo Kunderfranco; Nadia Polentarutti; Fabio Pasqualini; Sabrina Di Marco; Domenico Supino; Clelia Peano; Ferdinando Cananzi; Piergiuseppe Colombo; Silvana Pilotti; Suliman Yousef Alomar; Eduardo Bonavita; Maria Rosaria Galdiero; Cecilia Garlanda; Alberto Mantovani; Sebastien Jaillon
Journal:  Cell       Date:  2019-06-27       Impact factor: 41.582

9.  Comparison of gene expression profiling in sarcomas and mesenchymal stem cells identifies tumorigenic pathways in chemically induced rat sarcoma model.

Authors:  Kanya Honoki; Hiromasa Fujii; Yasuaki Tohma; Toshifumi Tsujiuchi; Akira Kido; Shinji Tsukamoto; Toshio Mori; Yasuhito Tanaka
Journal:  ISRN Oncol       Date:  2012-07-17

10.  Karyotype stability of human umbilical cord-derived mesenchymal stem cells during in vitro culture.

Authors:  Zhong-Bao Ruan; Li Zhu; Yi-Gang Yin; Ge-Cai Chen
Journal:  Exp Ther Med       Date:  2014-09-18       Impact factor: 2.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.